Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

A 7-year-old girl developed early pubic hair growth without other puberty signs, diagnosed as isolated premature pubarche.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document explains breast development, common breast conditions, and their treatments.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

Precocious puberty in girls is linked to cosmetics, pollution, light exposure, early sexual information, diet, and hereditary factors.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

A new mutation in the DCAF17 gene was found in a Chinese family, causing Woodhouse-Sakati syndrome and diabetes.

Cynomorium songaricum has many health benefits and could help with hair regrowth.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Wnt signaling is crucial for skin development and health, and its disruption can cause skin diseases.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Premature hair graying in young Turkish adults is more likely if they have stress, a family history of graying, drink alcohol, have chronic diseases, are older, or are taller.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Smoking and alcohol are linked to early hair graying.

Isolated pubic hair in infants is usually harmless and resolves on its own.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.